Natixis’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Natixis’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-87,740	Closed	-$3.7M	–	1161
2023 Q2	$3.7M	Sell	87,740 -15,260	-15%	-$617K	0.03%	329
2023 Q1	$3.67M	Buy	+103,000	New	+$3.74M	0.03%	322
2021 Q4	–	Sell	-20,100	Closed	-$1.76M	–	1389
2021 Q3	$1.76M	Buy	+20,100	New	+$1.82M	0.01%	749
2021 Q1	–	Sell	-43,800	Closed	-$2.98M	–	1213
2020 Q4	$2.98M	Buy	+43,800	New	+$2.73M	0.01%	607
2018 Q3	–	Sell	-74,484	Closed	-$3.49M	–	1006
2018 Q2	$3.49M	Buy	+74,484	New	+$3.08M	0.02%	431
2017 Q4	–	Sell	-213,852	Closed	-$11.2M	–	1245
2017 Q3	$11.2M	Buy	213,852 +8,755	+4%	+$488K	0.1%	181
2017 Q2	$12M	Sell	205,097 -2,811	-1%	-$146K	0.14%	151
2017 Q1	$9.53M	Buy	207,908 +41,300	+25%	+$2.05M	0.12%	169
2016 Q4	$8.76M	Sell	166,608 -9,857	-6%	-$477K	0.09%	199
2016 Q3	$7.87M	Buy	+176,465	New	+$7.65M	0.09%	160

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Natixis's SYNH Position: Q3 2023 in Review

Natixis sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 87,740 shares — an estimated $3.7M sold.

Natixis first reported a position in SYNH in Q3 2016 and held it in 10 quarters. The position peaked at $12M in Q2 2017. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Natixis reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Natixis sold 87,740 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $3.7M.
Natixis first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 10 quarters.
Natixis's Syneos Health, Inc. Class A Common Stock position peaked at $12M in Q2 2017.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.